The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Figure 1.19

CSR Figure 1.19: Person and Average Years of Life Lost by Cancer Site


Figure 1.19

Years of Life Lost in 2017 due to Cancer
All Races, Both Sexes

Person-Years of Life

Cancer SiteIncidence
Person-Years of Life Lost in Thousands of Years
All Cancer Sites 9303.0
Lung & Bronchus 2174.7
Colon & Rectum 829.1
Breast (Female) 780.6
Pancreas 660.4
Liver & IBD 454.3
Leukemia 359.5
Brain & ONS 357.8
Prostate 306.6
Non-Hodgkin Lymphoma 278.6
Ovary 250.5
Esophagus 244.6
Kidney & Renal Pelvis 215.1
Corpus & Uterus, NOS 191.4
Stomach 185.3
Urinary Bladder 185.3
Oral Cavity & Pharynx 170.6
Myeloma 164.9
Melanoma of the Skin 132.5
Cervix Uteri 111.3
Childhood Ages (0-14) 88.6
Hodgkin Lymphoma 19.4
Testis 15.3

Average Years of Life Lost

Cancer SiteIncidence
Average Years of Life Lost in Years
Childhood Ages (0-14) 71.7
Testis 36.0
Cervix Uteri 26.5
Brain & ONS 21.3
Hodgkin Lymphoma 19.2
Breast (Female) 18.6
Ovary 17.6
Corpus & Uterus, NOS 17.4
Oral Cavity & Pharynx 16.8
Liver & IBD 16.8
Stomach 16.6
Melanoma of the Skin 16.5
Esophagus 16.0
Colon & Rectum 15.8
All Cancer Sites 15.5
Kidney & Renal Pelvis 15.4
Leukemia 15.3
Pancreas 15.0
Lung & Bronchus 14.9
Non-Hodgkin Lymphoma 13.6
Myeloma 13.4
Urinary Bladder 11.1
Prostate 10.1

Footnotes:

Source: US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention and 2017 Life Tables.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.